Abstract
HCV infection is a major public health problem worldwide and affects approximately 150 million people chronically, being associated with the development of cirrhosis and liver cancer related deaths. Presently there is no vaccine available to prevent the disease, and the standard treatment, which consists of ribavirin combined with pegylated interferon-±, might not be efficient for half of…